WMSA
IRWD icon

Weiss Multi-Strategy Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-71,640
Closed -$899K – 586
2017
Q4 		$899K Sell
71,640
-59,700
-45% -$780K 0.02% 453
2017
Q3 		$1.74M Hold
131,340
– – 0.06% 324
2017
Q2 		$2.08M Sell
131,340
-17,910
-12% -$260K 0.09% 278
2017
Q1 		$2.13M Buy
149,250
+4,776
+3% +$65.3K 0.08% 267
2016
Q4 		$1.85M Buy
144,474
+29,850
+26% +$377K 0.09% 213
2016
Q3 		$1.52M Sell
114,624
-2,884
-2% -$33.7K 0.09% 245
2016
Q2 		$1.29M Sell
117,508
-85,472
-42% -$835K 0.1% 237
2016
Q1 		$1.86M Buy
202,980
+51,342
+34% +$423K 0.08% 276
2015
Q4 		$1.47M Hold
151,638
– – 0.1% 204
2015
Q3 		$1.32M Buy
151,638
+14,328
+10% +$134K 0.06% 231
2015
Q2 		$1.39M Buy
137,310
+23,880
+21% +$278K 0.05% 293
2015
Q1 		$1.52M Buy
113,430
+11,940
+12% +$157K 0.07% 276
2014
Q4 		$1.3M Sell
101,490
-77,610
-43% -$888K 0.04% 252
2014
Q3 		$1.94M Sell
179,100
-5,970
-3% -$68.3K 0.05% 312
2014
Q2 		$2.38M Buy
185,070
+14,698
+9% +$160K 0.05% 310
2014
Q1 		$1.76M Buy
170,372
+38,181
+29% +$429K 0.04% 375
2013
Q4 		$1.28M Buy
132,191
+18,759
+17% +$168K 0.03% 392
2013
Q3 		$1.13M Sell
113,432
-17,908
-14% -$176K 0.02% 393
2013
Q2 		$1.09M Buy
+131,340
New +$1.59M 0.03% 376

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Weiss Multi-Strategy Advisers's IRWD Position: Q1 2018 in Review

Weiss Multi-Strategy Advisers sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2018, closing a stake of 71,640 shares — an estimated $899K sold.

Weiss Multi-Strategy Advisers first reported a position in IRWD in Q2 2013 and held it in 19 quarters. The position peaked at $2.38M in Q2 2014. 149 funds tracked by Wall St. Rank hold IRWD as of Q1 2018.

  • Weiss Multi-Strategy Advisers reported no remaining Ironwood Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 71,640 Ironwood Pharmaceuticals shares in Q1 2018, an estimated $899K.
  • Weiss Multi-Strategy Advisers first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • Weiss Multi-Strategy Advisers's Ironwood Pharmaceuticals position peaked at $2.38M in Q2 2014.
  • 149 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2018, filed 15 May 2018.